Right Ventricular Dysfunction and Ventriculo‐Arterial Uncoupling in Heart Failure With Preserved Ejection Fraction: A Phenotype‐Specific Review of Mechanisms, Diagnosis, and Therapeutic Strategies
Oct 2026· Clinical Cardiology· Vol 49· 0 citations· 110 references
Medicine
TL;DR
This review synthesizes current evidence on the pathophysiological mechanisms, advanced diagnostic modalities, prognostic implications, and phenotype‐specific therapies for RV dysfunction in HFpEF, advocating for a transition to systematic biventricular evaluation.
Abstract
ABSTRACT Background Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all global heart failure cases. Historically viewed as a left‐centric diastolic disorder, emerging evidence identifies right ventricular (RV) dysfunction and impaired ventriculo‐arterial (RV‐PA) coupling as central drivers of exercise intolerance, functional decline, and adverse clinical outcomes. Objectives This review synthesizes current evidence on the pathophysiological mechanisms, advanced diagnostic modalities, prognostic implications, and phenotype‐specific therapies for RV dysfunction in HFpEF, advocating for a transition to systematic biventricular evaluation. Methods A structured, PRISMA‐informed search of PubMed and Scopus (2015–2024) identified 74 eligible studies evaluating RV structure, function, and hemodynamics in HFpEF cohorts. Results RV dysfunction is prevalent in 19% to 33% of HFpEF patients and independently predicts all‐cause mortality and heart failure hospitalizations. Key pathophysiological drivers include post‐capillary pulmonary hypertension, impaired RV lusitropy, systemic inflammation, and inter‐ventricular dependence. Non‐invasive markers notably speckle‐tracking echocardiography, 4D‐flow cardiac magnetic resonance (CMR), and the TAPSE/PASP ratio enable early identification of subclinical RV‐PA uncoupling. While traditional heart failure therapies show limited efficacy, emerging options including SGLT2 inhibitors, interatrial shunt devices, GLP‐1 receptor agonists, and targeted pulmonary vasodilators demonstrate potential to preserve RV strain and restore hemodynamics across distinct clinical phenotypes. Conclusions RV dysfunction is a major prognostic marker in HFpEF. Routine inclusion of RV‐PA coupling indices in diagnostic and risk‐stratification algorithms is essential to guide precision‐based, phenotype‐guided management and improve clinical trajectories.
BACKGROUND
While right ventricular dysfunction (RVD) is critical to the progression of heart failure (HF), the prevalence and prognostic implications of RVD across HF subtypes remains poorly understood.
OBJECTIVES
We aimed to characterize differences in hemodynamic indices of RVD among patients with HF with preserved...
L. Kosyakovsky, Juhi K. Parekh, L. Mounsey et al.· Journal of Cardiac Failure· 0 citations
Right ventricular-pulmonary artery coupling (RV-PA) reflects the interaction between ventricular performance and arterial load and is traditionally assessed using pressure-volume loops analysis. In acute heart failure (AHF), direct assessment of RV-PA coupling is rarely feasible due to the practical limitations o...
D. Guz, R. Filipescu, R. Radu et al.· European Heart Journal· 0 citations
No single clinical, imaging, or hemodynamic measure reliably predicts early RHF, and existing scores perform variably on external validation, so management begins by addressing reversible causes and optimizing LVAD support.
Qing Gao, Shu-Jie Yan, Kun-Yu Li et al.· Cardiovascular Therapeutics· 0 citations
Despite contemporary reperfusion therapy, a subset of STEMI patients develops heart failure (HF) during follow-up, including those with preserved or mildly reduced left ventricular ejection fraction (LVEF), suggesting mechanisms beyond global systolic dysfunction.
To evaluate whether integrative assessment...
J. Vratonjic, S. Stanković, G. Krljanac et al.· European Heart Journal· 0 citations
It is suggested that TSAT levels may serve as a critical indicator for identifying patients at high risk for persistent RV-PA coupling failure and subsequent adverse outcomes, as well as identifying patients whose TAPSE/PASP ratio remains persistently low after discharge.
Y. Fukunaga, A. Suzuki, A. Mikami et al.· European Heart Journal· 0 citations
Heart failure (HF) with improved ejection fraction (HFimpEF) was recently defined as a distinct clinical phenotype within the HF spectrum. Despite increasing recognition, its prognostic determinants remain incompletely characterized.
Right ventricular (RV) to pulmonary artery (PA) coupling is acknowledged as an...
C. Harsan, C. Delcea, A. Buzea et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.